Wound Care Devices Global Market Report 2024

The wound care devices market size has grown strongly in recent years. It will grow from $60.43 billion in 2023 to $65.51 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The expansion observed in the historical period can be credited to an increase in chronic diseases, the widespread prevalence of diabetes, a rise in surgical procedures, emphasis on infection control, governmental initiatives for wound care, and a patient preference for non-invasive solutions.

The wound care devices market size is expected to see strong growth in the next few years. It will grow to $88.47 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. The anticipated expansion in the forecast period can be ascribed to the global increase in obesity rates, regulatory support, and standards, the introduction of wearable wound monitoring devices, a growing geriatric population, and collaborative efforts in wound care research. Key trends expected in the forecast period encompass the development of smart wound dressings, the application of 3D bioprinting in wound care, the integration of telemedicine in wound management, innovations in compression therapy, and the adoption of wearable wound monitoring devices.

The utilization of combination dressings for treating chronic wounds is on the rise. One prevalent form of combination dressing involves the incorporation of an antimicrobial agent and a biological material, combining their chemical and physical properties. This results in a dressing that offers waterproofing, antibacterial and antiviral properties, and is skin-friendly. A notable example is ConvaTec's AQUACEL combination dressings, utilizing Hydrofiber Technology to enhance tensile strength for the treatment of chronic wounds. Commonly used combination dressings include silver alginate dressings, silver collagen dressings, collagen hydrochloride dressings, and foam dressings, employed in the treatment of chronic ulcers, traumatic wounds, and surgical wounds. The global prevalence of type 2 diabetes is expected to rise to 7,079 cases per 100,000 people by 2030, as reported by the National Library of Medicine.

The anticipated growth in the wound care devices dressing market is driven by the increasing number of accidents. Accidents, often causing harm or injury, necessitate the use of wound care devices to facilitate proper wound healing and prevent infections. In 2021, according to the National Highway Traffic Safety Administration, 42,915 individuals died in traffic accidents involving motor vehicles, reflecting a 10.5% increase compared to 2020. Deaths in multi-vehicle accidents and on city streets rose by 16% in 2021 compared to the previous year, indicating a surge in accidents and bolstering the growth of the wound care devices market.

Manufacturers in the wound care device industry should prioritize the development of products such as hydrocolloid dressings to enhance treatment effectiveness and user experience. Hydrocolloid dressings, incorporating gel-forming components with silicone or polyurethane adhesives, are advanced, self-adhering wound care products providing a moisture-filled environment for healing. These dressings are waterproof and invisible, suitable for burns with moderate severity and granular wounds, protecting healed skin by absorbing moisture and preventing swelling. For example, BenQ, a Japan-based consumer electronics company, offers a hydrocolloid dressing with high moisture absorption and UV ray protection to facilitate wound healing.

Prominent companies in the wound care device market are concentrating on innovative approaches, particularly the development of a bio-inductive implant, to maintain their market standing. This implant is specifically designed to contribute to wound care by bolstering the body's natural healing response and promoting the growth of tendon tissue. For example, in July 2023, the UK-based medical equipment manufacturing company Smith and Nephew introduced the REGENTEN bio-inductive implant in India. This collagen-based implant, known as REGENETEN Bio inductive Implant, is formulated to support the body's natural healing response, fostering the growth of new tendon-such as tissue to biologically enhance the existing tendon and alter the course of disease progression.


Major companies operating in the wound care devices market report are Cardinal Health Inc., Johnson & Johnson, 3M Company, Medtronic Inc., EssilorLuxottica SA, Siemens Healthineers, Fresenius Medical Care AG & Co. KGaA, Essity AB, Boston Scientific Corporation, Henry Schein Inc., B. Braun SE, Olympus Corporation, Zimmer Biomet Holdings Inc., Terumo Corporation, Intuitive Surgical Inc., Smith & Nephew PLC, Dentsply Sirona, Cadence, Coloplast A/S, Paul Hartmann AG, Mölnlycke Health Care, ConvaTec Group PLC, Integra lifeSciences, Lohmann & Rauscher, CONMED Corporation, Acelity, Frankenman International Limited, Human Biosciences Inc., Urgo Medical, Meril Life Science Pvt. Ltd., Danaher Corporation.

Asia-Pacific was the largest region in the global wound care devices market in 2023. North America was the second largest region in the global wound care devices market. Africa. was the smallest region in the global wound care devices market. The regions covered in the wound care devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the wound care devices market report are Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa. The wound care devices market consists of sales of instruments such as non-woven dressings, gauzes, hydrocolloids dressings, and others. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.


The primary categories of wound care devices include traditional adhesive dressings, negative-pressure wound therapy (NPWT), traditional gauze dressings, and advanced wound care devices. Traditional wound dressing products such as gauze, lint, plasters, bandages, and cotton wool are dry and are employed as either primary or secondary dressings to protect wounds from contaminants. Expenditure on these products can be either public or private, involving instruments/equipment and disposables. The diverse end-users for these devices encompass hospitals and clinics, diagnostic laboratories, and other healthcare facilities.


The wound care devices market research report is one of a series of new reports that provides wound care devices market statistics, including wound care devices industry global market size, regional shares, competitors with a wound care devices market share, detailed wound care devices market segments, market trends and opportunities, and any further data you may need to thrive in the wound care devices industry. This wound care devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.